Skip to content
Subscriber Only
Markets

Turkish Trials Show China’s Sinovac Shot to Be 83.5% Effective

The Sinovac Covid-19 vaccine has delivered vastly varying efficacy rates in four clinical trial sites.

The Sinovac Covid-19 vaccine has delivered vastly varying efficacy rates in four clinical trial sites.

Photographer: Dimas Ardian/Bloomberg
By

Turkish trials found China’s Sinovac inoculation to be 83.5% effective against the coronavirus, a level of protection that’s lower than the country’s initial predictions but significantly above Brazilian estimates.

The CoronaVac shot made by Sinovac Biotech Ltd. was 100% effective in preventing hospitalization, according to the Phase 3 trials by the prestigious Hacettepe University in Ankara, state-run Anadolu Agency reported.